OCUCYCLINE 1% EYE OINTMENT

Indications

• Conjunctivitis
• Glaucoma
• Dry eye syndrome
• Ocular inflammation
• Allergic conjunctivitis
• Intraocular pressure reduction
• Corneal ulcers

Dosage

Children: Refer to specific product information, as pediatric dosing is generally determined based on age, weight, and specific condition.

Adults: Refer to specific product information, as dosing can vary widely based on the medication and condition being treated.

Mechanism of action

Ophthalmic medications exert their effects through various mechanisms depending on their class. For instance, anti-inflammatory ophthalmic agents, such as corticosteroids, inhibit the production of inflammatory mediators, while antibiotics target bacterial cell wall synthesis or protein synthesis, leading to cell death. Beta-blockers used in glaucoma reduce intraocular pressure by decreasing aqueous humor production, and prostaglandin analogs enhance aqueous outflow.

Pharmacodynamics

The pharmacodynamics of ophthalmic drugs varies widely. Generally, they are designed to achieve local effects with minimal systemic absorption. This localized action helps to reduce side effects while maximizing therapeutic efficacy. The onset and duration of action also depend on the formulation and specific drug class. For example, topical anesthetics provide rapid pain relief, while anti-glaucoma agents may take longer to achieve their effects.

Pharmacokinetics

Ophthalmic drugs are primarily absorbed through the conjunctival and corneal tissues. Factors influencing pharmacokinetics include the drug's molecular size, lipophilicity, and formulation. After administration, systemic absorption can occur, but it is usually minimal due to the eye's anatomical barriers. The half-life of these drugs can vary; for example, drops may have a shorter duration of action compared to ointments due to differences in retention time on the ocular surface.

Contra-indications

• Hypersensitivity to the active substance or any of the excipients
• Active ocular infections
• Use in patients with narrow-angle glaucoma

Adverse effects

• Burning sensation in the eyes
• Stinging upon instillation
• Dry eyes
• Redness of the conjunctiva
• Increased intraocular pressure
• Allergic reactions

Interactions

• Other ophthalmic solutions may dilute the effect of the drug
• Systemic medications that increase intraocular pressure may have additive effects

Precautions

• Use with caution in patients with a history of eye surgery
• Monitor intraocular pressure in patients with a history of glaucoma
• Avoid touching the tip of the applicator to any surface to prevent contamination

Pregnancy

Safety in pregnancy has not been established. Use only if clearly needed and the benefit outweighs the risk.

Breast-feeding

Minimal risk to nursing infants; however, caution is advised. Monitor for any adverse effects.

Storage

Store at room temperature, away from light. Do not freeze. Discard any unused solution after the expiry date.

Formulations

• Ophthalmic solution
• Ophthalmic gel
• Ophthalmic ointment

Indications

• Bacterial infections such as chlamydia
• Rickettsial infections
• Mycoplasma infections
• Acne vulgaris (off-label use)

Dosage

Children: In children aged 12 to 17 years, the recommended dose for susceptible infections is 100 mg daily, but this can vary based on specific circumstances and should be guided by the BNF for Children

Adults: For susceptible infections, the typical adult dose is 100 mg twice daily for 5 to 14 days, depending on the specific infection. For acne, 500 mg twice daily for 6 to 12 weeks may be used.

Mechanism of action

Tetracycline works by binding to the 30S ribosomal subunit of bacteria, inhibiting the attachment of aminoacyl-tRNA to the ribosomal acceptor site. This effectively prevents protein synthesis, which is essential for bacterial growth and replication.

Pharmacodynamics

The pharmacodynamics of tetracycline involves its bacteriostatic action, meaning it stops bacteria from multiplying rather than killing them outright. Its spectrum of activity covers a wide range of gram-positive and gram-negative bacteria, as well as some atypical pathogens. Resistance can develop through various mechanisms, including efflux pumps and ribosomal protection.

Pharmacokinetics

Tetracycline is well-absorbed from the gastrointestinal tract, although its absorption can be decreased by the presence of divalent and trivalent metal ions (such as calcium, magnesium, and iron). It is distributed widely in body tissues and fluids, with a volume of distribution of approximately 0.5-1.0 L/kg. Tetracycline is largely excreted unchanged in the urine, with a half-life ranging from 6 to 12 hours. Renal impairment can increase its half-life, necessitating caution in dosing.

Contra-indications

• Children under 12 years due to deposition in growing bone and teeth, causing staining and occasionally dental hypoplasia

Adverse effects

• Gastrointestinal disturbances
• Hearing impairment
• Discoloration of teeth
• Photosensitivity
• Dizziness
• Vertigo
• Skin reactions such as rash or pruritus
• Allergic reactions including anaphylaxis
• Esophagitis
• Stomatitis
• Pseudomembranous colitis

Interactions

• Strontium and tetracyclines: Severe (decreases absorption)
• Fosphenytoin and tetracyclines: Moderate (decreases concentration)
• Tetracyclines and lithium: Moderate (increases risk of lithium toxicity)
• Rifampicin and tetracyclines: Moderate (decreases exposure)
• Mitotane and tetracyclines: Unknown (decreases exposure)
• St John's Wort and tetracyclines: Unknown (decreases exposure)
• Tetracycline and antimalarials: Unknown (decreases concentration)
• Tetracycline and atovaquone: Unknown (decreases concentration)
• Tetracycline and relugolix: Unknown (increases exposure)

Precautions

• Use with caution in patients with renal impairment, as dose adjustments may be necessary
• Monitor for hepatotoxicity, pigmentation, and systemic lupus erythematosus in long-term use
• Avoid concurrent use with medications that may affect absorption or increase toxicity
• Advise patients to remain upright for at least 30 minutes after taking to prevent esophageal irritation

Pregnancy

Tetracyclines are generally not recommended during pregnancy due to the risk of dental staining and skeletal abnormalities in the developing fetus.

Breast-feeding

Tetracyclines can be excreted in breast milk and may affect the infant's dental development; caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Formulations

• Tablets: 250 mg, 500 mg
• Oral suspension